LILLY DRN

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersEli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's…

Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and showing safety comparable with popular…

Nikos Pekiaridis | Lightrocket | Getty ImagesPfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The…

A pharmacist collects medications for prescriptions at a pharmacy.Simon Dawson | Bloomberg | Getty ImagesPresident Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences for…

The Lilly Biotechnology Center in San Diego, California, on March 1, 2023.Mike Blake | ReutersShares of some drugmakers rose on Wednesday after President Donald Trump said he would pause steep tariff rates on dozens of countries,…

Arseniy45 | Istock | Getty ImagesPresident Donald Trump may hope his tariffs jump-start a renaissance in manufacturing in the United States, but the reality is not so simple, according to experts.The president announced sweeping tariffs…

The Eli Lilly logo is shown on one of the company's offices in San Diego, California, on Sept. 17, 2020.Mike Blake | ReutersEli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the…

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease. The pill lowered the…

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesPatients, doctors and investors will soon learn a lot more about a new, more convenient…

This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn't look like much has changed. Popular websites like Amble,…